nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A16—Doxorubicin—uterine cancer	0.351	0.506	CbGbCtD
L-Carnitine—MPO—Carboplatin—uterine cancer	0.106	0.152	CbGbCtD
L-Carnitine—XDH—Carboplatin—uterine cancer	0.106	0.152	CbGbCtD
L-Carnitine—SLC22A5—Dactinomycin—uterine cancer	0.0705	0.102	CbGbCtD
L-Carnitine—XDH—Doxorubicin—uterine cancer	0.0605	0.0873	CbGbCtD
L-Carnitine—SLC22A16—renal system—uterine cancer	0.00369	0.0278	CbGeAlD
L-Carnitine—SLC25A20—myometrium—uterine cancer	0.00319	0.024	CbGeAlD
L-Carnitine—CRAT—myometrium—uterine cancer	0.00309	0.0233	CbGeAlD
L-Carnitine—SLC22A16—female reproductive system—uterine cancer	0.00295	0.0223	CbGeAlD
L-Carnitine—CROT—uterine cervix—uterine cancer	0.00285	0.0215	CbGeAlD
L-Carnitine—SLC25A29—endometrium—uterine cancer	0.00281	0.0212	CbGeAlD
L-Carnitine—CROT—smooth muscle tissue—uterine cancer	0.00277	0.0209	CbGeAlD
L-Carnitine—CROT—decidua—uterine cancer	0.00272	0.0205	CbGeAlD
L-Carnitine—CROT—mammalian vulva—uterine cancer	0.00249	0.0188	CbGeAlD
L-Carnitine—SLC25A20—uterine cervix—uterine cancer	0.00248	0.0187	CbGeAlD
L-Carnitine—MPO—artery—uterine cancer	0.00244	0.0184	CbGeAlD
L-Carnitine—CRAT—uterine cervix—uterine cancer	0.00241	0.0181	CbGeAlD
L-Carnitine—CPT2—myometrium—uterine cancer	0.00238	0.0179	CbGeAlD
L-Carnitine—CROT—uterus—uterine cancer	0.00238	0.0179	CbGeAlD
L-Carnitine—SLC25A20—decidua—uterine cancer	0.00236	0.0178	CbGeAlD
L-Carnitine—CRAT—smooth muscle tissue—uterine cancer	0.00234	0.0176	CbGeAlD
L-Carnitine—SLC25A29—female reproductive system—uterine cancer	0.00233	0.0175	CbGeAlD
L-Carnitine—SLC25A20—renal system—uterine cancer	0.00232	0.0175	CbGeAlD
L-Carnitine—CRAT—decidua—uterine cancer	0.00229	0.0173	CbGeAlD
L-Carnitine—CRAT—renal system—uterine cancer	0.00225	0.017	CbGeAlD
L-Carnitine—SLC25A20—endometrium—uterine cancer	0.00224	0.0169	CbGeAlD
L-Carnitine—CRAT—endometrium—uterine cancer	0.00218	0.0164	CbGeAlD
L-Carnitine—SLC25A20—mammalian vulva—uterine cancer	0.00217	0.0163	CbGeAlD
L-Carnitine—CROT—female reproductive system—uterine cancer	0.00214	0.0161	CbGeAlD
L-Carnitine—SLC25A29—female gonad—uterine cancer	0.00212	0.016	CbGeAlD
L-Carnitine—CRAT—mammalian vulva—uterine cancer	0.00211	0.0159	CbGeAlD
L-Carnitine—SLC25A20—uterus—uterine cancer	0.00207	0.0156	CbGeAlD
L-Carnitine—CRAT—uterus—uterine cancer	0.00201	0.0151	CbGeAlD
L-Carnitine—CROT—female gonad—uterine cancer	0.00194	0.0146	CbGeAlD
L-Carnitine—CROT—vagina—uterine cancer	0.00193	0.0146	CbGeAlD
L-Carnitine—SLC25A20—female reproductive system—uterine cancer	0.00186	0.014	CbGeAlD
L-Carnitine—CPT2—uterine cervix—uterine cancer	0.00185	0.0139	CbGeAlD
L-Carnitine—CPT1A—renal system—uterine cancer	0.00182	0.0137	CbGeAlD
L-Carnitine—CRAT—female reproductive system—uterine cancer	0.0018	0.0136	CbGeAlD
L-Carnitine—CPT2—decidua—uterine cancer	0.00176	0.0133	CbGeAlD
L-Carnitine—CPT2—renal system—uterine cancer	0.00173	0.013	CbGeAlD
L-Carnitine—SLC25A20—female gonad—uterine cancer	0.00169	0.0127	CbGeAlD
L-Carnitine—SLC25A20—vagina—uterine cancer	0.00168	0.0127	CbGeAlD
L-Carnitine—CPT2—endometrium—uterine cancer	0.00167	0.0126	CbGeAlD
L-Carnitine—CRAT—female gonad—uterine cancer	0.00164	0.0124	CbGeAlD
L-Carnitine—CRAT—vagina—uterine cancer	0.00163	0.0123	CbGeAlD
L-Carnitine—CPT2—mammalian vulva—uterine cancer	0.00162	0.0122	CbGeAlD
L-Carnitine—CPT2—uterus—uterine cancer	0.00154	0.0116	CbGeAlD
L-Carnitine—CPT1A—female reproductive system—uterine cancer	0.00146	0.011	CbGeAlD
L-Carnitine—XDH—uterine cervix—uterine cancer	0.00144	0.0109	CbGeAlD
L-Carnitine—CPT2—female reproductive system—uterine cancer	0.00139	0.0104	CbGeAlD
L-Carnitine—SLC25A29—lymph node—uterine cancer	0.00136	0.0103	CbGeAlD
L-Carnitine—XDH—renal system—uterine cancer	0.00135	0.0102	CbGeAlD
L-Carnitine—CES1—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00134	0.0262	CbGpPWpGaD
L-Carnitine—CPT1A—female gonad—uterine cancer	0.00133	0.01	CbGeAlD
L-Carnitine—CPT1A—vagina—uterine cancer	0.00132	0.00996	CbGeAlD
L-Carnitine—XDH—endometrium—uterine cancer	0.0013	0.00982	CbGeAlD
L-Carnitine—CPT2—female gonad—uterine cancer	0.00126	0.00951	CbGeAlD
L-Carnitine—XDH—mammalian vulva—uterine cancer	0.00126	0.0095	CbGeAlD
L-Carnitine—CPT2—vagina—uterine cancer	0.00125	0.00945	CbGeAlD
L-Carnitine—CROT—lymph node—uterine cancer	0.00125	0.00941	CbGeAlD
L-Carnitine—XDH—Oxidative Stress—NFE2L2—uterine cancer	0.00122	0.0238	CbGpPWpGaD
L-Carnitine—XDH—Oxidative Stress—GPX3—uterine cancer	0.00116	0.0227	CbGpPWpGaD
L-Carnitine—SLC25A20—lymph node—uterine cancer	0.00109	0.00819	CbGeAlD
L-Carnitine—XDH—female reproductive system—uterine cancer	0.00108	0.00814	CbGeAlD
L-Carnitine—SLC22A4—myometrium—uterine cancer	0.00108	0.00811	CbGeAlD
L-Carnitine—CRAT—lymph node—uterine cancer	0.00105	0.00794	CbGeAlD
L-Carnitine—XDH—vagina—uterine cancer	0.000977	0.00736	CbGeAlD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000941	0.0184	CbGpPWpGaD
L-Carnitine—MPO—epithelium—uterine cancer	0.000926	0.00697	CbGeAlD
L-Carnitine—SLCO1B1—renal system—uterine cancer	0.000883	0.00666	CbGeAlD
L-Carnitine—MPO—renal system—uterine cancer	0.000859	0.00647	CbGeAlD
L-Carnitine—CPT1A—lymph node—uterine cancer	0.000855	0.00644	CbGeAlD
L-Carnitine—CES1—female reproductive system—uterine cancer	0.000823	0.0062	CbGeAlD
L-Carnitine—CPT2—lymph node—uterine cancer	0.000811	0.00611	CbGeAlD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.0008	0.0156	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.0008	0.0156	CbGpPWpGaD
L-Carnitine—SLC22A4—decidua—uterine cancer	0.000799	0.00602	CbGeAlD
L-Carnitine—SLC22A4—renal system—uterine cancer	0.000784	0.00591	CbGeAlD
L-Carnitine—SLC22A4—endometrium—uterine cancer	0.000758	0.00571	CbGeAlD
L-Carnitine—CES1—female gonad—uterine cancer	0.000749	0.00564	CbGeAlD
L-Carnitine—MPO—IL23-mediated signaling events—SOCS3—uterine cancer	0.000718	0.014	CbGpPWpGaD
L-Carnitine—SLC22A5—myometrium—uterine cancer	0.000713	0.00537	CbGeAlD
L-Carnitine—CES1—E2F transcription factor network—RRM2—uterine cancer	0.000712	0.0139	CbGpPWpGaD
L-Carnitine—SLCO1B1—female reproductive system—uterine cancer	0.000708	0.00533	CbGeAlD
L-Carnitine—MPO—Folate Metabolism—GPX3—uterine cancer	0.000707	0.0138	CbGpPWpGaD
L-Carnitine—SLC22A8—renal system—uterine cancer	0.000686	0.00517	CbGeAlD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00068	0.0133	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00068	0.0133	CbGpPWpGaD
L-Carnitine—CES1—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.000679	0.0133	CbGpPWpGaD
L-Carnitine—SLC22A4—female reproductive system—uterine cancer	0.000628	0.00473	CbGeAlD
L-Carnitine—Muscle spasms—Progesterone—uterine cancer	0.000623	0.00505	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—STK11—uterine cancer	0.000615	0.012	CbGpPWpGaD
L-Carnitine—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.000612	0.00496	CcSEcCtD
L-Carnitine—Hypercalcaemia—Epirubicin—uterine cancer	0.000612	0.00496	CcSEcCtD
L-Carnitine—SLCO1B1—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	0.000601	0.0117	CbGpPWpGaD
L-Carnitine—Anaemia—Progesterone—uterine cancer	0.000599	0.00485	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—STAR—uterine cancer	0.000594	0.0116	CbGpPWpGaD
L-Carnitine—Vertigo—Progesterone—uterine cancer	0.000582	0.00472	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000578	0.0113	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000578	0.0113	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000578	0.0113	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000578	0.0113	CbGpPWpGaD
L-Carnitine—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.000575	0.00466	CcSEcCtD
L-Carnitine—Palpitations—Progesterone—uterine cancer	0.000573	0.00464	CcSEcCtD
L-Carnitine—SLC22A4—vagina—uterine cancer	0.000568	0.00428	CbGeAlD
L-Carnitine—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.000568	0.0046	CcSEcCtD
L-Carnitine—Hypercalcaemia—Doxorubicin—uterine cancer	0.000566	0.00459	CcSEcCtD
L-Carnitine—Cough—Progesterone—uterine cancer	0.000565	0.00458	CcSEcCtD
L-Carnitine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000564	0.00457	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—GPX3—uterine cancer	0.000561	0.011	CbGpPWpGaD
L-Carnitine—Convulsion—Progesterone—uterine cancer	0.000561	0.00455	CcSEcCtD
L-Carnitine—Hypertension—Progesterone—uterine cancer	0.000559	0.00453	CcSEcCtD
L-Carnitine—SLC22A5—uterine cervix—uterine cancer	0.000555	0.00418	CbGeAlD
L-Carnitine—CPT1A—RORA activates circadian gene expression—EP300—uterine cancer	0.000552	0.0108	CbGpPWpGaD
L-Carnitine—Chest pain—Progesterone—uterine cancer	0.000552	0.00447	CcSEcCtD
L-Carnitine—Myalgia—Progesterone—uterine cancer	0.000552	0.00447	CcSEcCtD
L-Carnitine—Amblyopia—Epirubicin—uterine cancer	0.00055	0.00446	CcSEcCtD
L-Carnitine—Anxiety—Progesterone—uterine cancer	0.00055	0.00445	CcSEcCtD
L-Carnitine—XDH—Nucleotide metabolism—RRM2—uterine cancer	0.000549	0.0107	CbGpPWpGaD
L-Carnitine—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000543	0.0044	CcSEcCtD
L-Carnitine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000527	0.00427	CcSEcCtD
L-Carnitine—Infection—Progesterone—uterine cancer	0.000525	0.00426	CcSEcCtD
L-Carnitine—Pharyngitis—Dactinomycin—uterine cancer	0.000522	0.00423	CcSEcCtD
L-Carnitine—SLC22A5—renal system—uterine cancer	0.000519	0.00391	CbGeAlD
L-Carnitine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000519	0.0042	CcSEcCtD
L-Carnitine—Tachycardia—Progesterone—uterine cancer	0.000516	0.00418	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000515	0.0101	CbGpPWpGaD
L-Carnitine—Amblyopia—Doxorubicin—uterine cancer	0.000509	0.00413	CcSEcCtD
L-Carnitine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000509	0.00412	CcSEcCtD
L-Carnitine—Anorexia—Progesterone—uterine cancer	0.000504	0.00408	CcSEcCtD
L-Carnitine—SLC22A5—endometrium—uterine cancer	0.000502	0.00378	CbGeAlD
L-Carnitine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.0005	0.00405	CcSEcCtD
L-Carnitine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.0005	0.00405	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000499	0.00975	CbGpPWpGaD
L-Carnitine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000498	0.00404	CcSEcCtD
L-Carnitine—Hypotension—Progesterone—uterine cancer	0.000494	0.004	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—GPX3—uterine cancer	0.000491	0.00959	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—HNF1B—uterine cancer	0.000484	0.00946	CbGpPWpGaD
L-Carnitine—Cardiovascular disorder—Epirubicin—uterine cancer	0.000484	0.00392	CcSEcCtD
L-Carnitine—CES1—lymph node—uterine cancer	0.000482	0.00363	CbGeAlD
L-Carnitine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000482	0.0039	CcSEcCtD
L-Carnitine—Insomnia—Progesterone—uterine cancer	0.000478	0.00388	CcSEcCtD
L-Carnitine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000476	0.00386	CcSEcCtD
L-Carnitine—Paraesthesia—Progesterone—uterine cancer	0.000475	0.00385	CcSEcCtD
L-Carnitine—Dyspnoea—Progesterone—uterine cancer	0.000471	0.00382	CcSEcCtD
L-Carnitine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000468	0.00379	CcSEcCtD
L-Carnitine—Dyspepsia—Progesterone—uterine cancer	0.000465	0.00377	CcSEcCtD
L-Carnitine—SLCO1B1—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	0.000463	0.00904	CbGpPWpGaD
L-Carnitine—Decreased appetite—Progesterone—uterine cancer	0.00046	0.00373	CcSEcCtD
L-Carnitine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000457	0.0037	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Progesterone—uterine cancer	0.000456	0.0037	CcSEcCtD
L-Carnitine—Pain—Progesterone—uterine cancer	0.000452	0.00366	CcSEcCtD
L-Carnitine—Constipation—Progesterone—uterine cancer	0.000452	0.00366	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—CCL2—uterine cancer	0.000451	0.00881	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000448	0.00876	CbGpPWpGaD
L-Carnitine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000448	0.00363	CcSEcCtD
L-Carnitine—Cardiovascular disorder—Doxorubicin—uterine cancer	0.000448	0.00363	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—MTHFR—uterine cancer	0.000446	0.00871	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000437	0.00354	CcSEcCtD
L-Carnitine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000433	0.00351	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Progesterone—uterine cancer	0.000432	0.0035	CcSEcCtD
L-Carnitine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00043	0.00349	CcSEcCtD
L-Carnitine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000427	0.00346	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000424	0.00829	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000424	0.00829	CbGpPWpGaD
L-Carnitine—Anaemia—Dactinomycin—uterine cancer	0.000423	0.00343	CcSEcCtD
L-Carnitine—Injection site reaction—Epirubicin—uterine cancer	0.000422	0.00342	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—NFE2L2—uterine cancer	0.000422	0.00825	CbGpPWpGaD
L-Carnitine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000422	0.00342	CcSEcCtD
L-Carnitine—CROT—Metabolism—NDUFB11—uterine cancer	0.000419	0.00818	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—SRD5A2—uterine cancer	0.000419	0.00818	CbGpPWpGaD
L-Carnitine—Abdominal pain—Progesterone—uterine cancer	0.000418	0.00339	CcSEcCtD
L-Carnitine—Body temperature increased—Progesterone—uterine cancer	0.000418	0.00339	CcSEcCtD
L-Carnitine—Hyperkalaemia—Epirubicin—uterine cancer	0.000418	0.00338	CcSEcCtD
L-Carnitine—Renal failure—Etoposide—uterine cancer	0.000417	0.00338	CcSEcCtD
L-Carnitine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000416	0.00338	CcSEcCtD
L-Carnitine—SLC22A5—female reproductive system—uterine cancer	0.000416	0.00313	CbGeAlD
L-Carnitine—Melaena—Epirubicin—uterine cancer	0.000415	0.00336	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000414	0.00335	CcSEcCtD
L-Carnitine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00041	0.00332	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000407	0.00795	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—GPX3—uterine cancer	0.000403	0.00787	CbGpPWpGaD
L-Carnitine—MPO—lymph node—uterine cancer	0.000402	0.00303	CbGeAlD
L-Carnitine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000392	0.00318	CcSEcCtD
L-Carnitine—Injection site reaction—Doxorubicin—uterine cancer	0.000391	0.00317	CcSEcCtD
L-Carnitine—Cramps of lower extremities—Epirubicin—uterine cancer	0.00039	0.00316	CcSEcCtD
L-Carnitine—Myalgia—Dactinomycin—uterine cancer	0.00039	0.00316	CcSEcCtD
L-Carnitine—Hypersensitivity—Progesterone—uterine cancer	0.00039	0.00316	CcSEcCtD
L-Carnitine—Hyperkalaemia—Doxorubicin—uterine cancer	0.000386	0.00313	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000384	0.00751	CbGpPWpGaD
L-Carnitine—Melaena—Doxorubicin—uterine cancer	0.000384	0.00311	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.000382	0.00746	CbGpPWpGaD
L-Carnitine—Asthenia—Progesterone—uterine cancer	0.000379	0.00307	CcSEcCtD
L-Carnitine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000379	0.00307	CcSEcCtD
L-Carnitine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000379	0.00307	CcSEcCtD
L-Carnitine—SLC22A5—female gonad—uterine cancer	0.000378	0.00285	CbGeAlD
L-Carnitine—SLC22A5—vagina—uterine cancer	0.000376	0.00283	CbGeAlD
L-Carnitine—Pruritus—Progesterone—uterine cancer	0.000374	0.00303	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000373	0.00728	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000373	0.00728	CbGpPWpGaD
L-Carnitine—Hypertonia—Epirubicin—uterine cancer	0.000372	0.00302	CcSEcCtD
L-Carnitine—Infection—Dactinomycin—uterine cancer	0.000371	0.00301	CcSEcCtD
L-Carnitine—SLC22A4—lymph node—uterine cancer	0.000367	0.00277	CbGeAlD
L-Carnitine—MPO—Folate Metabolism—MTHFR—uterine cancer	0.000363	0.00709	CbGpPWpGaD
L-Carnitine—Diarrhoea—Progesterone—uterine cancer	0.000362	0.00293	CcSEcCtD
L-Carnitine—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000361	0.00293	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000357	0.00698	CbGpPWpGaD
L-Carnitine—Anorexia—Dactinomycin—uterine cancer	0.000356	0.00289	CcSEcCtD
L-Carnitine—CRAT—Metabolism—NDUFB11—uterine cancer	0.000356	0.00696	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—NDUFB11—uterine cancer	0.000356	0.00696	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—SRD5A2—uterine cancer	0.000356	0.00696	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—SRD5A2—uterine cancer	0.000356	0.00696	CbGpPWpGaD
L-Carnitine—Eye disorder—Etoposide—uterine cancer	0.000356	0.00288	CcSEcCtD
L-Carnitine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000353	0.00286	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.000353	0.00689	CbGpPWpGaD
L-Carnitine—Dizziness—Progesterone—uterine cancer	0.00035	0.00283	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—CCL2—uterine cancer	0.000349	0.00682	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000346	0.00676	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000346	0.00676	CbGpPWpGaD
L-Carnitine—Angiopathy—Etoposide—uterine cancer	0.000345	0.0028	CcSEcCtD
L-Carnitine—Hypertonia—Doxorubicin—uterine cancer	0.000345	0.00279	CcSEcCtD
L-Carnitine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000344	0.00279	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00034	0.00276	CcSEcCtD
L-Carnitine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000339	0.00275	CcSEcCtD
L-Carnitine—Vomiting—Progesterone—uterine cancer	0.000336	0.00272	CcSEcCtD
L-Carnitine—Rash—Progesterone—uterine cancer	0.000333	0.0027	CcSEcCtD
L-Carnitine—Dermatitis—Progesterone—uterine cancer	0.000333	0.0027	CcSEcCtD
L-Carnitine—Headache—Progesterone—uterine cancer	0.000331	0.00268	CcSEcCtD
L-Carnitine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000328	0.00266	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000327	0.00638	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000327	0.00638	CbGpPWpGaD
L-Carnitine—Decreased appetite—Dactinomycin—uterine cancer	0.000325	0.00263	CcSEcCtD
L-Carnitine—Dysgeusia—Etoposide—uterine cancer	0.000325	0.00263	CcSEcCtD
L-Carnitine—Back pain—Etoposide—uterine cancer	0.000321	0.0026	CcSEcCtD
L-Carnitine—Pain—Dactinomycin—uterine cancer	0.00032	0.00259	CcSEcCtD
L-Carnitine—Muscle spasms—Etoposide—uterine cancer	0.000319	0.00258	CcSEcCtD
L-Carnitine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000317	0.00257	CcSEcCtD
L-Carnitine—Nausea—Progesterone—uterine cancer	0.000314	0.00255	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—EZH2—uterine cancer	0.000311	0.00607	CbGpPWpGaD
L-Carnitine—Anaemia—Etoposide—uterine cancer	0.000306	0.00248	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000306	0.00248	CcSEcCtD
L-Carnitine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000305	0.00247	CcSEcCtD
L-Carnitine—CROT—Metabolism—AKR1B1—uterine cancer	0.000303	0.00592	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—STAR—uterine cancer	0.000303	0.00592	CbGpPWpGaD
L-Carnitine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000302	0.00245	CcSEcCtD
L-Carnitine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000302	0.00245	CcSEcCtD
L-Carnitine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0003	0.00243	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000299	0.00585	CbGpPWpGaD
L-Carnitine—Vertigo—Etoposide—uterine cancer	0.000298	0.00241	CcSEcCtD
L-Carnitine—Abdominal pain—Dactinomycin—uterine cancer	0.000295	0.00239	CcSEcCtD
L-Carnitine—Body temperature increased—Dactinomycin—uterine cancer	0.000295	0.00239	CcSEcCtD
L-Carnitine—CPT1A—Circadian Clock—EP300—uterine cancer	0.000294	0.00574	CbGpPWpGaD
L-Carnitine—Cough—Etoposide—uterine cancer	0.000289	0.00234	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000288	0.00563	CbGpPWpGaD
L-Carnitine—Convulsion—Etoposide—uterine cancer	0.000287	0.00233	CcSEcCtD
L-Carnitine—Hypertension—Etoposide—uterine cancer	0.000286	0.00232	CcSEcCtD
L-Carnitine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.00231	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—CCL2—uterine cancer	0.000284	0.00555	CbGpPWpGaD
L-Carnitine—Chest pain—Etoposide—uterine cancer	0.000282	0.00229	CcSEcCtD
L-Carnitine—Hypersensitivity—Dactinomycin—uterine cancer	0.000275	0.00223	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000273	0.00534	CbGpPWpGaD
L-Carnitine—Gastritis—Epirubicin—uterine cancer	0.000273	0.00221	CcSEcCtD
L-Carnitine—Muscular weakness—Epirubicin—uterine cancer	0.000272	0.00221	CcSEcCtD
L-Carnitine—Infection—Etoposide—uterine cancer	0.000269	0.00218	CcSEcCtD
L-Carnitine—Asthenia—Dactinomycin—uterine cancer	0.000268	0.00217	CcSEcCtD
L-Carnitine—Influenza—Epirubicin—uterine cancer	0.000267	0.00216	CcSEcCtD
L-Carnitine—Tachycardia—Etoposide—uterine cancer	0.000264	0.00214	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000258	0.00505	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000258	0.00505	CbGpPWpGaD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—uterine cancer	0.000258	0.00504	CbGpPWpGaD
L-Carnitine—Anorexia—Etoposide—uterine cancer	0.000258	0.00209	CcSEcCtD
L-Carnitine—CRAT—Metabolism—AKR1B1—uterine cancer	0.000258	0.00503	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—STAR—uterine cancer	0.000258	0.00503	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—STAR—uterine cancer	0.000258	0.00503	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKR1B1—uterine cancer	0.000258	0.00503	CbGpPWpGaD
L-Carnitine—Bronchitis—Epirubicin—uterine cancer	0.000256	0.00208	CcSEcCtD
L-Carnitine—Diarrhoea—Dactinomycin—uterine cancer	0.000256	0.00207	CcSEcCtD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000255	0.00498	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000255	0.00497	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000255	0.00497	CbGpPWpGaD
L-Carnitine—Hypotension—Etoposide—uterine cancer	0.000253	0.00205	CcSEcCtD
L-Carnitine—Gastritis—Doxorubicin—uterine cancer	0.000253	0.00205	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000252	0.00492	CbGpPWpGaD
L-Carnitine—Muscular weakness—Doxorubicin—uterine cancer	0.000252	0.00204	CcSEcCtD
L-Carnitine—Influenza—Doxorubicin—uterine cancer	0.000247	0.002	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—CDKN2A—uterine cancer	0.000246	0.0048	CbGpPWpGaD
L-Carnitine—CPT2—PPARA activates gene expression—EP300—uterine cancer	0.000244	0.00476	CbGpPWpGaD
L-Carnitine—SLC22A5—lymph node—uterine cancer	0.000243	0.00183	CbGeAlD
L-Carnitine—Paraesthesia—Etoposide—uterine cancer	0.000243	0.00197	CcSEcCtD
L-Carnitine—Weight increased—Epirubicin—uterine cancer	0.000243	0.00197	CcSEcCtD
L-Carnitine—Weight decreased—Epirubicin—uterine cancer	0.000241	0.00195	CcSEcCtD
L-Carnitine—Dyspnoea—Etoposide—uterine cancer	0.000241	0.00195	CcSEcCtD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000238	0.00466	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—POLD1—uterine cancer	0.000238	0.00464	CbGpPWpGaD
L-Carnitine—Vomiting—Dactinomycin—uterine cancer	0.000238	0.00193	CcSEcCtD
L-Carnitine—Bronchitis—Doxorubicin—uterine cancer	0.000237	0.00192	CcSEcCtD
L-Carnitine—Rash—Dactinomycin—uterine cancer	0.000236	0.00191	CcSEcCtD
L-Carnitine—Decreased appetite—Etoposide—uterine cancer	0.000235	0.00191	CcSEcCtD
L-Carnitine—Renal failure—Epirubicin—uterine cancer	0.000234	0.00189	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000234	0.00189	CcSEcCtD
L-Carnitine—Constipation—Etoposide—uterine cancer	0.000231	0.00187	CcSEcCtD
L-Carnitine—Pain—Etoposide—uterine cancer	0.000231	0.00187	CcSEcCtD
L-Carnitine—Urinary tract infection—Epirubicin—uterine cancer	0.000231	0.00187	CcSEcCtD
L-Carnitine—CPT2—Metabolism—NDUFB11—uterine cancer	0.00023	0.00448	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SRD5A2—uterine cancer	0.00023	0.00448	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—PIK3CA—uterine cancer	0.000226	0.00442	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—CCL2—uterine cancer	0.000226	0.00441	CbGpPWpGaD
L-Carnitine—Weight increased—Doxorubicin—uterine cancer	0.000225	0.00182	CcSEcCtD
L-Carnitine—Weight decreased—Doxorubicin—uterine cancer	0.000223	0.00181	CcSEcCtD
L-Carnitine—Sinusitis—Epirubicin—uterine cancer	0.000223	0.00181	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000223	0.00436	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKR1C1—uterine cancer	0.000222	0.00434	CbGpPWpGaD
L-Carnitine—Nausea—Dactinomycin—uterine cancer	0.000222	0.0018	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Etoposide—uterine cancer	0.000221	0.00179	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—CDKN1B—uterine cancer	0.000218	0.00425	CbGpPWpGaD
L-Carnitine—Renal failure—Doxorubicin—uterine cancer	0.000216	0.00175	CcSEcCtD
L-Carnitine—Haemoglobin—Epirubicin—uterine cancer	0.000214	0.00174	CcSEcCtD
L-Carnitine—Rhinitis—Epirubicin—uterine cancer	0.000214	0.00173	CcSEcCtD
L-Carnitine—Abdominal pain—Etoposide—uterine cancer	0.000214	0.00173	CcSEcCtD
L-Carnitine—Body temperature increased—Etoposide—uterine cancer	0.000214	0.00173	CcSEcCtD
L-Carnitine—Urinary tract infection—Doxorubicin—uterine cancer	0.000214	0.00173	CcSEcCtD
L-Carnitine—Haemorrhage—Epirubicin—uterine cancer	0.000213	0.00173	CcSEcCtD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000212	0.00415	CbGpPWpGaD
L-Carnitine—Pharyngitis—Epirubicin—uterine cancer	0.000212	0.00172	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000211	0.00411	CbGpPWpGaD
L-Carnitine—Oedema peripheral—Epirubicin—uterine cancer	0.00021	0.0017	CcSEcCtD
L-Carnitine—Sinusitis—Doxorubicin—uterine cancer	0.000206	0.00167	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000204	0.00399	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—POLD1—uterine cancer	0.000202	0.00395	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—POLD1—uterine cancer	0.000202	0.00395	CbGpPWpGaD
L-Carnitine—Eye disorder—Epirubicin—uterine cancer	0.000199	0.00162	CcSEcCtD
L-Carnitine—Hypersensitivity—Etoposide—uterine cancer	0.000199	0.00162	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—uterine cancer	0.000198	0.00161	CcSEcCtD
L-Carnitine—CROT—Metabolism—RRM2—uterine cancer	0.000198	0.00387	CbGpPWpGaD
L-Carnitine—Rhinitis—Doxorubicin—uterine cancer	0.000198	0.0016	CcSEcCtD
L-Carnitine—Haemorrhage—Doxorubicin—uterine cancer	0.000197	0.0016	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—CCL2—uterine cancer	0.000197	0.00385	CbGpPWpGaD
L-Carnitine—Pharyngitis—Doxorubicin—uterine cancer	0.000196	0.00159	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—uterine cancer	0.000195	0.00158	CcSEcCtD
L-Carnitine—Asthenia—Etoposide—uterine cancer	0.000194	0.00157	CcSEcCtD
L-Carnitine—Angiopathy—Epirubicin—uterine cancer	0.000194	0.00157	CcSEcCtD
L-Carnitine—CROT—Metabolism—DCN—uterine cancer	0.000192	0.00376	CbGpPWpGaD
L-Carnitine—Pruritus—Etoposide—uterine cancer	0.000191	0.00155	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—EP300—uterine cancer	0.000191	0.00373	CbGpPWpGaD
L-Carnitine—Arrhythmia—Epirubicin—uterine cancer	0.000191	0.00155	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00019	0.0037	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKR1C1—uterine cancer	0.000189	0.00369	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKR1C1—uterine cancer	0.000189	0.00369	CbGpPWpGaD
L-Carnitine—Diarrhoea—Etoposide—uterine cancer	0.000185	0.0015	CcSEcCtD
L-Carnitine—Eye disorder—Doxorubicin—uterine cancer	0.000185	0.0015	CcSEcCtD
L-Carnitine—Dysgeusia—Epirubicin—uterine cancer	0.000182	0.00147	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—PIK3CA—uterine cancer	0.000181	0.00354	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CYP11A1—uterine cancer	0.000181	0.00354	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CDKN1B—uterine cancer	0.000181	0.00353	CbGpPWpGaD
L-Carnitine—Back pain—Epirubicin—uterine cancer	0.00018	0.00146	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—uterine cancer	0.000179	0.00145	CcSEcCtD
L-Carnitine—Dizziness—Etoposide—uterine cancer	0.000179	0.00145	CcSEcCtD
L-Carnitine—Muscle spasms—Epirubicin—uterine cancer	0.000179	0.00145	CcSEcCtD
L-Carnitine—Arrhythmia—Doxorubicin—uterine cancer	0.000176	0.00143	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—TP53—uterine cancer	0.000175	0.00343	CbGpPWpGaD
L-Carnitine—Vomiting—Etoposide—uterine cancer	0.000172	0.00139	CcSEcCtD
L-Carnitine—Anaemia—Epirubicin—uterine cancer	0.000172	0.00139	CcSEcCtD
L-Carnitine—CROT—Metabolism—AKR1C3—uterine cancer	0.000171	0.00334	CbGpPWpGaD
L-Carnitine—Rash—Etoposide—uterine cancer	0.000171	0.00138	CcSEcCtD
L-Carnitine—Dermatitis—Etoposide—uterine cancer	0.00017	0.00138	CcSEcCtD
L-Carnitine—Headache—Etoposide—uterine cancer	0.000169	0.00137	CcSEcCtD
L-Carnitine—CPT1A—PPARA activates gene expression—EP300—uterine cancer	0.000169	0.0033	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—RRM2—uterine cancer	0.000168	0.00329	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—RRM2—uterine cancer	0.000168	0.00329	CbGpPWpGaD
L-Carnitine—Dysgeusia—Doxorubicin—uterine cancer	0.000168	0.00136	CcSEcCtD
L-Carnitine—Vertigo—Epirubicin—uterine cancer	0.000167	0.00135	CcSEcCtD
L-Carnitine—Back pain—Doxorubicin—uterine cancer	0.000166	0.00135	CcSEcCtD
L-Carnitine—CPT2—Metabolism—STAR—uterine cancer	0.000166	0.00324	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKR1B1—uterine cancer	0.000166	0.00324	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000166	0.00324	CbGpPWpGaD
L-Carnitine—Muscle spasms—Doxorubicin—uterine cancer	0.000165	0.00134	CcSEcCtD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000165	0.00323	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000164	0.00321	CbGpPWpGaD
L-Carnitine—Palpitations—Epirubicin—uterine cancer	0.000164	0.00133	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000164	0.0032	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—DCN—uterine cancer	0.000164	0.00319	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—DCN—uterine cancer	0.000164	0.00319	CbGpPWpGaD
L-Carnitine—Cough—Epirubicin—uterine cancer	0.000162	0.00131	CcSEcCtD
L-Carnitine—Convulsion—Epirubicin—uterine cancer	0.000161	0.0013	CcSEcCtD
L-Carnitine—Nausea—Etoposide—uterine cancer	0.000161	0.0013	CcSEcCtD
L-Carnitine—Hypertension—Epirubicin—uterine cancer	0.00016	0.0013	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—SRD5A2—uterine cancer	0.000159	0.00311	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NDUFB11—uterine cancer	0.000159	0.00311	CbGpPWpGaD
L-Carnitine—Anaemia—Doxorubicin—uterine cancer	0.000159	0.00129	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—EP300—uterine cancer	0.000159	0.0031	CbGpPWpGaD
L-Carnitine—Chest pain—Epirubicin—uterine cancer	0.000158	0.00128	CcSEcCtD
L-Carnitine—Myalgia—Epirubicin—uterine cancer	0.000158	0.00128	CcSEcCtD
L-Carnitine—Anxiety—Epirubicin—uterine cancer	0.000158	0.00128	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000155	0.00302	CbGpPWpGaD
L-Carnitine—Vertigo—Doxorubicin—uterine cancer	0.000154	0.00125	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—CYP11A1—uterine cancer	0.000154	0.00301	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP11A1—uterine cancer	0.000154	0.00301	CbGpPWpGaD
L-Carnitine—Palpitations—Doxorubicin—uterine cancer	0.000152	0.00123	CcSEcCtD
L-Carnitine—Infection—Epirubicin—uterine cancer	0.000151	0.00122	CcSEcCtD
L-Carnitine—Cough—Doxorubicin—uterine cancer	0.00015	0.00122	CcSEcCtD
L-Carnitine—Convulsion—Doxorubicin—uterine cancer	0.000149	0.00121	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000149	0.00291	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—NRAS—uterine cancer	0.000148	0.0029	CbGpPWpGaD
L-Carnitine—Hypertension—Doxorubicin—uterine cancer	0.000148	0.0012	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—AKT1—uterine cancer	0.000148	0.00289	CbGpPWpGaD
L-Carnitine—Tachycardia—Epirubicin—uterine cancer	0.000148	0.0012	CcSEcCtD
L-Carnitine—Myalgia—Doxorubicin—uterine cancer	0.000146	0.00119	CcSEcCtD
L-Carnitine—Chest pain—Doxorubicin—uterine cancer	0.000146	0.00119	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000146	0.00285	CbGpPWpGaD
L-Carnitine—Anxiety—Doxorubicin—uterine cancer	0.000146	0.00118	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—AKR1C3—uterine cancer	0.000146	0.00284	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKR1C3—uterine cancer	0.000146	0.00284	CbGpPWpGaD
L-Carnitine—Anorexia—Epirubicin—uterine cancer	0.000145	0.00117	CcSEcCtD
L-Carnitine—Hypotension—Epirubicin—uterine cancer	0.000142	0.00115	CcSEcCtD
L-Carnitine—Infection—Doxorubicin—uterine cancer	0.000139	0.00113	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000138	0.00112	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—TP53—uterine cancer	0.000138	0.00269	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.000137	0.00268	CbGpPWpGaD
L-Carnitine—Insomnia—Epirubicin—uterine cancer	0.000137	0.00111	CcSEcCtD
L-Carnitine—Tachycardia—Doxorubicin—uterine cancer	0.000137	0.00111	CcSEcCtD
L-Carnitine—Paraesthesia—Epirubicin—uterine cancer	0.000136	0.0011	CcSEcCtD
L-Carnitine—Dyspnoea—Epirubicin—uterine cancer	0.000135	0.0011	CcSEcCtD
L-Carnitine—Anorexia—Doxorubicin—uterine cancer	0.000134	0.00108	CcSEcCtD
L-Carnitine—Dyspepsia—Epirubicin—uterine cancer	0.000133	0.00108	CcSEcCtD
L-Carnitine—CROT—Metabolism—STK11—uterine cancer	0.000133	0.0026	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CYP19A1—uterine cancer	0.000133	0.0026	CbGpPWpGaD
L-Carnitine—Decreased appetite—Epirubicin—uterine cancer	0.000132	0.00107	CcSEcCtD
L-Carnitine—Hypotension—Doxorubicin—uterine cancer	0.000131	0.00106	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000131	0.00106	CcSEcCtD
L-Carnitine—CPT2—Metabolism—POLD1—uterine cancer	0.00013	0.00254	CbGpPWpGaD
L-Carnitine—Constipation—Epirubicin—uterine cancer	0.00013	0.00105	CcSEcCtD
L-Carnitine—Pain—Epirubicin—uterine cancer	0.00013	0.00105	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000128	0.00104	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—KRAS—uterine cancer	0.000128	0.0025	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000128	0.00249	CbGpPWpGaD
L-Carnitine—Insomnia—Doxorubicin—uterine cancer	0.000127	0.00103	CcSEcCtD
L-Carnitine—Paraesthesia—Doxorubicin—uterine cancer	0.000126	0.00102	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000125	0.00244	CbGpPWpGaD
L-Carnitine—Dyspnoea—Doxorubicin—uterine cancer	0.000125	0.00101	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000125	0.00244	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000125	0.00243	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000124	0.001	CcSEcCtD
L-Carnitine—Dyspepsia—Doxorubicin—uterine cancer	0.000123	0.001	CcSEcCtD
L-Carnitine—Decreased appetite—Doxorubicin—uterine cancer	0.000122	0.000988	CcSEcCtD
L-Carnitine—CPT2—Metabolism—AKR1C1—uterine cancer	0.000122	0.00238	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000121	0.000982	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000121	0.00236	CbGpPWpGaD
L-Carnitine—Constipation—Doxorubicin—uterine cancer	0.00012	0.000972	CcSEcCtD
L-Carnitine—Pain—Doxorubicin—uterine cancer	0.00012	0.000972	CcSEcCtD
L-Carnitine—Body temperature increased—Epirubicin—uterine cancer	0.00012	0.000971	CcSEcCtD
L-Carnitine—Abdominal pain—Epirubicin—uterine cancer	0.00012	0.000971	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000119	0.00233	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKR1B1—uterine cancer	0.000115	0.00225	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—STAR—uterine cancer	0.000115	0.00225	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000115	0.00093	CcSEcCtD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000114	0.00222	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000114	0.00222	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—STK11—uterine cancer	0.000113	0.00221	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP19A1—uterine cancer	0.000113	0.00221	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP19A1—uterine cancer	0.000113	0.00221	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—STK11—uterine cancer	0.000113	0.00221	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000113	0.0022	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Epirubicin—uterine cancer	0.000112	0.000905	CcSEcCtD
L-Carnitine—Body temperature increased—Doxorubicin—uterine cancer	0.000111	0.000899	CcSEcCtD
L-Carnitine—Abdominal pain—Doxorubicin—uterine cancer	0.000111	0.000899	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—PTEN—uterine cancer	0.000109	0.00213	CbGpPWpGaD
L-Carnitine—Asthenia—Epirubicin—uterine cancer	0.000109	0.000882	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—HRAS—uterine cancer	0.000109	0.00212	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—RRM2—uterine cancer	0.000109	0.00212	CbGpPWpGaD
L-Carnitine—Pruritus—Epirubicin—uterine cancer	0.000107	0.000869	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000106	0.00208	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000106	0.00208	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—DCN—uterine cancer	0.000105	0.00206	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SRD5A2—uterine cancer	0.000105	0.00206	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NDUFB11—uterine cancer	0.000105	0.00206	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—EP300—uterine cancer	0.000104	0.00204	CbGpPWpGaD
L-Carnitine—Diarrhoea—Epirubicin—uterine cancer	0.000104	0.000841	CcSEcCtD
L-Carnitine—Hypersensitivity—Doxorubicin—uterine cancer	0.000103	0.000838	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000101	0.00198	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000101	0.00198	CbGpPWpGaD
L-Carnitine—Asthenia—Doxorubicin—uterine cancer	0.000101	0.000816	CcSEcCtD
L-Carnitine—Dizziness—Epirubicin—uterine cancer	0.0001	0.000813	CcSEcCtD
L-Carnitine—CROT—Metabolism—MTHFR—uterine cancer	0.0001	0.00196	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP11A1—uterine cancer	9.93e-05	0.00194	CbGpPWpGaD
L-Carnitine—Pruritus—Doxorubicin—uterine cancer	9.93e-05	0.000804	CcSEcCtD
L-Carnitine—Vomiting—Epirubicin—uterine cancer	9.64e-05	0.000781	CcSEcCtD
L-Carnitine—Diarrhoea—Doxorubicin—uterine cancer	9.6e-05	0.000778	CcSEcCtD
L-Carnitine—Rash—Epirubicin—uterine cancer	9.56e-05	0.000775	CcSEcCtD
L-Carnitine—Dermatitis—Epirubicin—uterine cancer	9.55e-05	0.000774	CcSEcCtD
L-Carnitine—Headache—Epirubicin—uterine cancer	9.5e-05	0.00077	CcSEcCtD
L-Carnitine—CPT2—Metabolism—AKR1C3—uterine cancer	9.38e-05	0.00183	CbGpPWpGaD
L-Carnitine—Dizziness—Doxorubicin—uterine cancer	9.28e-05	0.000752	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—POLD1—uterine cancer	9.03e-05	0.00176	CbGpPWpGaD
L-Carnitine—Nausea—Epirubicin—uterine cancer	9.01e-05	0.00073	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	9e-05	0.00176	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	9e-05	0.00176	CbGpPWpGaD
L-Carnitine—Vomiting—Doxorubicin—uterine cancer	8.92e-05	0.000723	CcSEcCtD
L-Carnitine—Rash—Doxorubicin—uterine cancer	8.85e-05	0.000717	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—uterine cancer	8.84e-05	0.000716	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.83e-05	0.00172	CbGpPWpGaD
L-Carnitine—Headache—Doxorubicin—uterine cancer	8.79e-05	0.000712	CcSEcCtD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.56e-05	0.00167	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—MTHFR—uterine cancer	8.52e-05	0.00166	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—MTHFR—uterine cancer	8.52e-05	0.00166	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKR1C1—uterine cancer	8.44e-05	0.00165	CbGpPWpGaD
L-Carnitine—Nausea—Doxorubicin—uterine cancer	8.33e-05	0.000675	CcSEcCtD
L-Carnitine—XDH—Metabolism—AKR1B1—uterine cancer	7.62e-05	0.00149	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—STAR—uterine cancer	7.62e-05	0.00149	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—RRM2—uterine cancer	7.52e-05	0.00147	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.51e-05	0.00147	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.51e-05	0.00147	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—uterine cancer	7.46e-05	0.00146	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—STK11—uterine cancer	7.3e-05	0.00143	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—DCN—uterine cancer	7.3e-05	0.00143	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP19A1—uterine cancer	7.3e-05	0.00143	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP11A1—uterine cancer	6.88e-05	0.00134	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.86e-05	0.00134	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.61e-05	0.00129	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.54e-05	0.00128	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKR1C3—uterine cancer	6.5e-05	0.00127	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—POLD1—uterine cancer	5.98e-05	0.00117	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKR1C1—uterine cancer	5.59e-05	0.00109	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTEN—uterine cancer	5.57e-05	0.00109	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SRD5A2—uterine cancer	5.55e-05	0.00108	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NDUFB11—uterine cancer	5.55e-05	0.00108	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—MTHFR—uterine cancer	5.49e-05	0.00107	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.39e-05	0.00105	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—EP300—uterine cancer	5.32e-05	0.00104	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.09e-05	0.000994	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP19A1—uterine cancer	5.06e-05	0.000989	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—STK11—uterine cancer	5.06e-05	0.000989	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—RRM2—uterine cancer	4.98e-05	0.000974	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—DCN—uterine cancer	4.84e-05	0.000945	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.84e-05	0.000945	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.75e-05	0.000928	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTEN—uterine cancer	4.74e-05	0.000926	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTEN—uterine cancer	4.74e-05	0.000926	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP11A1—uterine cancer	4.56e-05	0.000891	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.53e-05	0.000885	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—EP300—uterine cancer	4.52e-05	0.000883	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—EP300—uterine cancer	4.52e-05	0.000883	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKR1C3—uterine cancer	4.31e-05	0.000841	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKR1B1—uterine cancer	4.01e-05	0.000783	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—STAR—uterine cancer	4.01e-05	0.000783	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.96e-05	0.000774	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CA—uterine cancer	3.93e-05	0.000768	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—MTHFR—uterine cancer	3.8e-05	0.000743	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP19A1—uterine cancer	3.35e-05	0.000655	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—STK11—uterine cancer	3.35e-05	0.000655	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.35e-05	0.000655	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CA—uterine cancer	3.34e-05	0.000653	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CA—uterine cancer	3.34e-05	0.000653	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—uterine cancer	3.21e-05	0.000627	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—POLD1—uterine cancer	3.15e-05	0.000615	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTEN—uterine cancer	3.05e-05	0.000597	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKR1C1—uterine cancer	2.94e-05	0.000575	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—EP300—uterine cancer	2.91e-05	0.000569	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—uterine cancer	2.73e-05	0.000533	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—uterine cancer	2.73e-05	0.000533	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—RRM2—uterine cancer	2.62e-05	0.000512	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—DCN—uterine cancer	2.55e-05	0.000497	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MTHFR—uterine cancer	2.52e-05	0.000492	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP11A1—uterine cancer	2.4e-05	0.000469	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKR1C3—uterine cancer	2.27e-05	0.000443	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CA—uterine cancer	2.15e-05	0.000421	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTEN—uterine cancer	2.12e-05	0.000413	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—EP300—uterine cancer	2.02e-05	0.000394	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—STK11—uterine cancer	1.77e-05	0.000345	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP19A1—uterine cancer	1.77e-05	0.000345	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—uterine cancer	1.76e-05	0.000344	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.66e-05	0.000324	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.58e-05	0.000309	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CA—uterine cancer	1.49e-05	0.000292	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTEN—uterine cancer	1.4e-05	0.000274	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—EP300—uterine cancer	1.34e-05	0.000261	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTHFR—uterine cancer	1.33e-05	0.000259	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—uterine cancer	1.22e-05	0.000238	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.17e-05	0.000228	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CA—uterine cancer	9.89e-06	0.000193	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—uterine cancer	8.08e-06	0.000158	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTEN—uterine cancer	7.38e-06	0.000144	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—EP300—uterine cancer	7.04e-06	0.000137	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CA—uterine cancer	5.21e-06	0.000102	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—uterine cancer	4.25e-06	8.31e-05	CbGpPWpGaD
